Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Mallinckrodt
Express Scripts
Fish and Richardson
Dow
QuintilesIMS
Argus Health
Cipla
Harvard Business School

Generated: January 18, 2019

DrugPatentWatch Database Preview

X Gen Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for X GEN PHARMS, and what generic and branded alternatives to X GEN PHARMS drugs are available?

X GEN PHARMS has twenty approved drugs.



Summary for X Gen Pharms
US Patents:0
Tradenames:19
Ingredients:15
NDAs:20

Drugs and US Patents for X Gen Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
X Gen Pharms NEO-RX neomycin sulfate POWDER;FOR RX COMPOUNDING 061579-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
X Gen Pharms NEO-FRADIN neomycin sulfate SOLUTION;ORAL 065010-001 May 23, 2002 DISCN No No ➤ Sign Up ➤ Sign Up
X Gen Pharms POLY-RX polymyxin b sulfate POWDER;FOR RX COMPOUNDING 061578-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
X Gen Pharms BACIIM bacitracin INJECTABLE;INJECTION 064153-001 May 9, 1997 AP RX No No ➤ Sign Up ➤ Sign Up
X Gen Pharms NEOMYCIN AND POLYMYXIN B SULFATE neomycin sulfate; polymyxin b sulfate SOLUTION;IRRIGATION 065108-001 Jan 31, 2006 AT RX No No ➤ Sign Up ➤ Sign Up
X Gen Pharms NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 065220-001 Jul 28, 2006 AA RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Fish and Richardson
Accenture
Healthtrust
Julphar
Chubb
AstraZeneca
US Department of Justice
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.